Dendreon: Targeting Cancer, Transforming Lives
 

EXECUTIVE MANAGEMENT


BOARD OF DIRECTORS

  • Susan B. Bayh
    Former Distinguished Visiting Professor in the College of Business Administration at Butler University and Director of Multiple Companies
  • Richard B. Brewer (Chairman)
    Chairman of the Board, ARCA biopharma
  • Gerardo Canet
    Chairman, IntegraMed America, Inc.
  • Ian Clark
    Head of Global Product Strategy and Chief Marketing Officer, Roche, Pharma Division
  • Bogdan Dziurzynski, D.P.A.
    Consultant in Regulatory Affairs
  • Mitchell H. Gold, M.D.
    CEO, Dendreon Corporation
  • Pedro Granadillo
    Retired, Eli Lilly & Company
  • David L. Urdal, Ph.D.
    CSO, Dendreon Corporation
  • Douglas Watson
    Pittencrieff Glenn Associates